Finished product reference
Artificial Tears (Hyaluronate Sodium / Trehalose)
Solution, Drops · Ophthalmic · 0.15 %/3 % · 10 mL
- List code
- 52078
- Pharmacologic class
- Ocular lubricant (sodium hyaluronate / trehalose)
What it is and how it works
Sodium hyaluronate is a viscoelastic, water-retaining glycosaminoglycan that stabilises the tear film and promotes corneal epithelial healing. Trehalose is a disaccharide bioprotectant that protects corneal epithelial cells from desiccation and oxidative stress by stabilising cell membranes and proteins.
Indications
Symptomatic relief of moderate to severe dry eye and ocular surface discomfort, including after refractive surgery and with contact lens wear.
Dosage and administration (summary)
1 drop into each affected eye three to six times daily, or as required.
Contraindications
Hypersensitivity to any component.
Warnings and precautions
Transient blurred vision may occur after instillation. Avoid touching the dropper tip to the eye to prevent contamination. Seek medical review for persistent pain, redness or visual change.
Pregnancy
Considered safe for use in pregnancy.
Storage and supply
Store below 25 °C; use within the period stated after opening (commonly 3 months for preservative-free multidose systems).
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
- Gel · Ophthalmic · 0.2 % · 10 g50883
- Gel · Ophthalmic · 0.25 % · 0.5 g50308
- Gel · Ophthalmic · 0.25 % · 10 g50309
- Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 0.5 mL51905
- Solution, Drops · Ophthalmic · 0.2 %/0.2 % · 10 mL51906
- Solution, Drops · Ophthalmic · 0.15 % · 0.35 mL51900
- Solution, Drops · Ophthalmic · 0.15 % · 0.5 mL52909
- Solution, Drops · Ophthalmic · 0.15 % · 10 mL52910
- Solution, Drops · Ophthalmic · 0.2 %51703
- Solution, Drops · Ophthalmic · 0.3 % · 0.35 mL51990
- Solution, Drops · Ophthalmic · 0.4 % · 0.5 mL51904
- Solution, Drops · Ophthalmic · 0.4 % · 10 mL51907
- Solution, Drops · Ophthalmic · 0.5 % · 15 mL52004
- Gel · Ophthalmic · 0.2 % · 10 g19130
- Solution · Ophthalmic · 3.2 mg/1mL · 0.5 mL50429
- Solution · Ophthalmic · 3.2 mg/1mL · 10 mL51057
- Solution, Drops · Ophthalmic · 0.3 % · 0.5 mL51892
- Solution, Drops · Ophthalmic · 0.3 % · 10 mL51891
- Solution, Drops · Ophthalmic · 14 mg/1mL · 10 mL50647
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.